Correction: scFv-based biologics in diabetes: from therapeutic potential to clinical prospects - Top-Institutions - MDSpire

Correction: scFv-based biologics in diabetes: from therapeutic potential to clinical prospects

  • By

  • Shikun Ge

  • Luoxuan Wang

  • Yichen Huang

  • Huaizu Guo

  • Fuyao Wei

  • Pan Li

  • Siyuan Li

  • Qian Liu

  • Jin Xu

  • Yilei Xiao

  • Alberto Carlos Piress Dias

  • Lusha Ji

  • July 13, 2026

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Liaocheng University
    Liaocheng University

    Liaocheng, Shandong

    Key Differentiators

    • Endocrinology

  • #2

    Wenzhou Medical University
    Wenzhou Medical University

    Wenzhou, Zhejiang

    Key Differentiators

    • Endocrinology

  • #3

    University of Minho
    University of Minho

    Braga, Minho

    Key Differentiators

    • Endocrinology

  • #4

    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Diabetes and Digestive and Kidney Diseases

    Bethesda, Maryland

    Key Differentiators

    • Endocrinology

Original Source(s)

Correction: scFv-based biologics in diabetes: from therapeutic potential to clinical prospects

  • by Shikun Ge, Luoxuan Wang, Yichen Huang, Huaizu Guo, Fuyao Wei, Pan Li, Siyuan Li, Qian Liu, Jin Xu, Yilei Xiao, Alberto Carlos Piress Dias, Lusha Ji

  • July 13, 2026

Related Content

Serum adropin as a potential renoprotective factor in diabetic kidney disease: evidence from a Chinese elderly cohort and an experimental mouse model

Diagnosis and treatment progress of upper eyelid abnormalities in thyroid-eye disease

Sport: The Precision Medicine Vanguard

Armed with ever-more practical and powerful sampling devices, omics workflows, and wearable tech, could elite athletes pioneer a more precise approach to sport – and health?